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Abstract
Background. Pseudoaneurysms of the extrahepatic arterial vasculature are relatively uncommon lesions following surgery
and trauma. In this report we analyze the presentation, management and outcomes of these vascular lesions. Of the related
surgical procedures, the reported incidence is highest following laparoscopic cholecystectomy. We hereby analyze the
literature on this subject and report our experience, specifically with extrahepatic pseudoaneurysms, drawing an important
distinction from intrahepatic pseudoaneurysms. Methods. From September 1995 until July 2004, six patients, including
three males and three females with a mean age of 67 years, were treated for seven extrahepatic arterial pseudoaneurysms.
Patients were evaluated by endoscopy, ultrasound, computerized tomography, and angiography. Management included coil
embolization or arterial ligation and/or hepatic resection. Results. The mean pseudoaneurysm size was 4.9-cm (range 1.0
11.0-cm) and the locations included the right hepatic artery (n/5), inferior pancreaticoduodenal artery (n/1), and
gastroduodenal artery (n/1). All six patients had prior surgical or percutaneous procedures. Median latency period
between the original procedure and treatment of pseudoaneurysm was 17 weeks (range one month16 years). Clinical
features ranged from the dramatic presentation of hypotension secondary to intraperitoneal aneurysmal rupture to the
subtle presentation of obstructive jaundice secondary to pseudoaneurysm mass effect. The range of patient presentations
created diagnostic challenges, proving that accurate diagnosis is made only by early consideration of pseudoaneurysm.
Management was ligation of the right hepatic artery (n/4) and embolization of the pseudoaneurysms (n/2). Post-
treatment sequelae included liver failure requiring liver transplant (n/1), intrahepatic biloma requiring percutaneous
drainage (n/1) and cholangitis with right hepatic duct strictures requiring right lobectomy and biliary reconstruction (n/
1). These complications followed arterial ligation, with no complications resulting from embolization. All six patients are
alive and well after a mean follow-up of 53 months. Conclusions. Our six patients demonstrate the diversity and
unpredictability with which a pseudoaneurysm of the extrahepatic arterial vasculature may present in terms of initial
symptoms, prior procedures, and the latency period between presentation and prior procedure. Through our experience
and an analysis of the literature, we recommend a diagnostic and management approach for these patients.
Introduction
The initial descriptions of hepatic arterial pseudoa-
neurysms (PsA) were most often associated with
hepatic trauma; however, the increased use of percu-
taneous procedures and laparoscopic surgeries has
broadened the etiological scope of this disease [15].
Pseudoaneurysms are associated with laparoscopic
cholecystectomy [613], thoracocentesis [14], percu-
taneous liver biopsy [15,16], pancreaticoduodenect-
omy [1719], and liver transplantation [2022].
Iatrogenic injuries now account for approximately
twice as many PsA as accidental trauma with the
majority located intrahepatically [5,7].
Most PsA are intrahepatic and present with hemo-
bilia. Extrahepatic PsA may present with abdominal
pain, gastrointestinal hemorrhage, and hemobilia
[23,24]. Many PsA of the hepatic arterial vasculature,
however, may be asymptomatic prior to rupture.
Depending upon the presentation and the time from
the inciting factor, diagnosis may be difficult and
management of extrahepatic arterial PsA is not as well
delineated as for that of the intrahepatic type. Options
include embolization, stent-grafting, surgical ligation,
and resection.
We describe the clinical features and outcomes for
six patients at our institution with iatrogenic PsA of
the extrahepatic arterial vasculature. Combining our
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experience with an analysis of the literature, we make
recommendations for the approach to the diagnosis
and management of suspected PsA of the extrahepatic
arterial vasculature.
Patients and Methods
From September 1995 through July 2004, six patients
presented to the Hepatobiliary Surgery and Abdom-
inal Organ Transplantation Division at University
Hospital, University of Southern California with
seven PsA of the extrahepatic arterial vasculature. A
retrospective chart review was performed, with long-
term follow-up obtained by direct telephone contact.
Six patients (3 male/3 female) with mean age 67
years (range: 4880 years) presented with seven
extrahepatic PsA with a mean size of 4.9-cm (range
1.011.0-cm). Locations included right hepatic ar-
tery (n/5), inferior pancreaticoduodenal artery (n/
1) and gastroduodenal artery (n/1). All six patients
had one or more prior surgical procedures including
liver transplantation (n/1), percutaneous biopsy of
the pancreatic head (n/1), and open or laparoscopic
cholecystectomy with (n/3) or without (n/1) addi-
tional biliary tract procedures. Three of the four
patients with prior cholecystectomies had biliary tract
procedures within one month (n/2) and at nine
months (n/1) of the cholecystectomy for biliary tract
complications sustained at the time of cholecystect-
omy. The time from the original surgery to presenta-
tion ranged from one month to 16 years. Details of the
presentation and diagnostic evaluation of each patient
is delineated in Table I.
Presentations
Presentations varied and at times made the diagnosis
difficult (Table I). Patient 1 presented with acute
abdominal pain ten days and hypotension twelve days
following biliary tract reconstruction. The predomi-
nant presenting symptoms of Patients 2, 3 and 4 were
gastrointestinal bleeding four to eight weeks following
cholecystectomy with biliary tract complications (n/
2) and liver transplantation (n/1). Patients 5 and 6
presented with less urgent symptoms including jaun-
dice, pruritis and pancreatitis.
Diagnosis
Diagnostic modalities reflected the urgency status of
each patient and included endoscopy, computerized
tomography (CT), angiography and laparotomy. Pa-
tient 1 initially presented with abdominal pain raising
suspicion of a bile leak and prompting a CT scan
which demonstrated a 2.5-cm PsA with infarction of
the right lobe of the liver (Figures 1 and 2). While
there was no evidence of intraabdominal blood on the
CT scan, he promptly developed abdominal disten-
sion and hypotension requiring emergent surgery.
Patient 2 was properly diagnosed by CT scan follow-
ing a futile attempt to locate the bleeding source
endoscopically. Patient 3 was diagnosed by angiogra-
phy (Figures 3 and 4) after a failed attempt to control
bleeding from a presumed diagnosis of anastomotic
bleeding after prior biliary reconstruction. Patient 4
underwent multiple diagnostic procedures including
CT scan and angiography with embolization of a
5-cm PsA of the inferior pancreaticoduodenal artery
(IPDA). Continued bleeding with massive uncontrol-
lable bleeding into the duodenum noted on endo-
scopy, prompted a pancreaticoduodenectomy for
presumed rupture of the IPDA at which time the
diagnosis of a ruptured 2-cm PsA of the right hepatic
artery into the common bile duct was made. Both
patients 5 and 6 were diagnosed with CT scan
followed by angiography for better delineation to
determine therapeutic options (Figure 5).
Table I. Location, Size, and Presentation of Extrahepatic Pseudoaneurysm.
Patient Site
Size
(cm) Presentation Prior procedure
Latency
period
1 RHA 2.5 Pain, anemia, hypotension 1. Open cholecystectomy 9 months
2. Biliary reconstruction 10 days
2 RHA 5.0 Pain, gastrointestinal bleeding 1. Laparoscopic cholecystectomy 1 month
2. Biliary stent placement for cystic duct leak 5 days
3 RHA 1.0 Gastrointestinal bleeding, elevated
hepatic chemistries
1. Open cholecystectomy; hepaticojejunostomy
for biliary injury
6 weeks
2. Revision hepaticojejunostomy and
enteroenterostomy for presumed bleeding
2 weeks
3. Embolization PsA from RHA 1 week
4 1. RHA 5.0 Pain, gastrointestinal bleeding,
hypotension, pancreatitis
1. Liver transplantation 8 weeks
2. IPDA 2.0
5 RHA 11 Jaundice, pruritis 1. Open cholecystectomy 16 years
6 GDA 8.0 Pain, nausea, vomiting, anemia, pancreatitis 1. Percutaneous biopsy of pancreatic head 6 months
RHA  Right hepatic artery, IPDA  Inferior pancreaticoduodenal artery, GDA  Gastroduodenal artery.
Iatrogenic Pseudoaneurysms of the Extrahepatic Arterial Vasculature 459
Management
Of the six patients, four were managed with surgery
and two with coil embolization (Table II). Manage-
ment decisions were largely influenced by presenta-
tion and pre-management diagnosis. Patients 2 and 6
were stable at presentation and correctly diagnosed by
CT scan and angiography leading to management
with coil embolization (Figures 6 and 7). Patient 5
was correctly diagnosed with CT scan and angiogra-
phy and was managed with excision of the PsA and
ligation of the right hepatic artery due to the massive
size (11-cm) of the aneurysm leading to bile duct
compression and severe jaundice. Patients 1 and 4
underwent emergent surgery for massive bleeding,
which included ligation of a ruptured right hepaticFigure 2. Contrast enhanced CT demonstrating large area of
hepatic infarction (arrows).
Figure 3. Delayed image following celiac axis contrast injection
demonstrates a 1-cm pseudoaneurysm of the right hepatic artery,
immediately distal to the surgical clips (arrow).
Figure 1. Contrast enhanced CT demonstrating 2.5-cm hepatic
artery aneurysm (long arrow) and adjacent biliary stent (short
arrow). The patient is status post bile duct resection and biliary
reconstruction.
Figure 4. More delayed image from the same injection demon-
strates contrast in a loop of small bowel (arrow), indicating that the
pseudoaneurysm is the source of the patient’s GI bleed.
Figure 5. Patient 5: Contrast enhanced CT demonstrates a large,
thrombus containing pseudoaneurysm of the right hepatic artery.
The feeding artery is coursing along the lateral aspect, entering the
pseudoaneurysm anteriorly (arrow).
460 T. Christensen et al.
artery PsA and right lobectomy (Patient 1) and
pancreaticoduodenectomy (Patient 4). Following a
failed attempt at gelfoam embolization, Patient 3 was
managed with surgical ligation of a right hepatic
artery PsA at the same time as a required revision of
a biliary anastomosis.
Results
All six patients are alive and well after a mean follow-
up of 53 months (range 2184 months) (Table II).
Three patients, including the two treated with coil
embolization, had no significant sequelae. The other
three patients required further management for com-
plications of right hepatic artery occlusion. Patient 1
developed liver failure immediately after right hepatic
lobectomy and ligation of the right hepatic artery. He
underwent successful liver transplantation. Patient 3
developed cholangitis and was diagnosed with biliary
strictures at 15 months. A right hepatic lobectomy
and revision of a biliary anastomosis were performed.
Pathologic evaluation of the right lobe revealed well-
established fibrosis. These changes were not present
in the left lobe. Patient 4 returned with an infected
intrahepatic biloma that was percutaneously drained.
Cholangiogram demonstrated no biliary stricture and
there has been no recurrence.
Discussion
Presentation
The presentation of gastrointestinal bleeding follow-
ing an invasive upper abdominal procedure should
prompt consideration of the presence of a hepatic
artery PsA. The majority of hepatic PsA are iatro-
genic, as compared to pancreatic PsA, which are
usually caused by pancreatitis [25]. In a literature
review of 153 hepatic artery PsA (63% intrahepatic
and 37% extrahepatic), Tessier reports the common
presenting symptoms as hemobilia (64%), hematem-
esis (30%), hematochezia (14%), and abdominal pain
(20%), with some asymptomatic patients (10%) [7].
There may be other unusual presentations based upon
the size and location of the PsA including compressive
symptoms of jaundice and pruritis. Our six patients
demonstrate the wide spectrum of clinical presenta-
tions.
The prior history of hepato-pancreatico-biliary
procedures in all of our patients highlights the shifting
etiologic trend from traumatic to iatrogenic causation.
The six patients had a mean latency time of 142 weeks
(range 5 weeks16 years). Excluding Patient 5, mean
latency becomes 58 days, which is more likely to
provoke consideration of the correct diagnosis. While
the patient with a PsA is more likely to present in
the early post-operative period, the outliers demon-
strate that late presentation is possible.
Diagnosis
As the majority of patients present with gastrointest-
inal bleeding, initial evaluation generally includes
endoscopic procedures. Endoscopy may show bleed-
ing from the ampulla of Vater and can rule-out other
etiologies of bleeding. However, endoscopy often fails
to make the correct diagnosis and may even provide
misleading information. After failing to make a
diagnosis endoscopically, the diagnosis of PsA is
most commonly made by angiography [2,3,7,9,26].
Angiography can accurately diagnose PsA and offers
the therapeutic options of embolization or stenting. It
is useful in identifying additional aneurysms in the
vascular tree as 20% of hepatic aneurysms are multi-
ple [23]. Angiography also delineates feeding vessels
and fistulas. Both the celiac and superior mesenteric
arteries must be filled to avoid a false-negative result
due to the presence of a replaced right hepatic artery
and to delineate the hepatic arterial blood flow that is
important in determining the safety and feasibility of
hepatic artery occlusion [2,5,9].
The use of ultrasound has been recommended by
some as the initial test for suspected hepatic PsA [27].
Color flow Doppler shows pulsatile flow and confirms
Table II. Management, Sequelae, and Outcomes.
Patient Management Sequelae Management of Sequelae Result Follow-up
1 Ligation RHA; RHL Liver failure; sepsis Liver transplant Alive and well 21 months
2 Coil embolization None Alive and well 7 years







Alive and well 68 months
4* 1. Ligation RHA;
pancreaticoduodenectomy
Biloma at 3 years Percutaneous drainage Alive and well 7 years
2. Emboilization IPDA
5 Ligation RHA; excision PsA;
removal cystic duct stones
None Alive and well 38 months
6 Coil embolization None Alive and well 21 months
CT  Computerized tomography, PsA  Pseudoaneurysm, HA  Hepatic artery, RHA  Right hepatic artery, IPDA  Inferior
pancreaticoduodenal artery, GDA  Gastroduodenal artery, RHL  Right hepatic lobectomy, *  Patient with 2 pseudoaneurysms (IPDA
and RHA).
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vascular patency. Unfortunately, many patients with
gastrointestinal bleeding have significant bowel gas
that limits visualization with ultrasound. Ultrasound
is also highly operator-dependent, and patients’
symptoms often demand a more comprehensive
evaluation of the abdomen.
Dynamic computerized tomographic angiography
(CTA) is an excellent noninvasive examination for the
evaluation of visceral aneurysms and vascular anoma-
lies, especially in the stable patient. CT is commonly
used for the evaluation of aortic, visceral and renal
artery pathology as well as for the diagnosis of splenic
artery aneurysms [28]. CT is also useful for evalua-
tion of extravascular structures and should be per-
formed when the presentation is not related to
gastrointestinal bleed, such as in the case of Patients
1 and 5. In both of these patients, imaging was
performed for indications other than bleeding, and
was able to detect the hepatic PsA.
Magnetic resonance angiography (MRA), like
CTA, can be performed as a part of a comprehensive
examination of the abdomen. Contrast enhanced
MRA is a reliable, accurate way to evaluate vascular
morphology and has been used for evaluation of
mesenteric ischemia, visceral aneurysms, tumor en-
casement and surgical planning for liver donation
[2933]. There are non-contrast techniques that can
be used to evaluate blood flow, especially for the
evaluation of stenosis [34,35] MRA is an alternative
to CTA, especially in patients with iodinated contrast
allergy and renal insufficiency. MRA is also used when
reduction of radiation exposure is desired, such as
during pregnancy and in the pediatric population.
Although not used in the patients presented in this
paper, MR imaging would have been an appropriate
imaging choice for diagnosis in all but the most
unstable.
Management
PsA of the hepatic arterial vasculature have a well-
documented propensity for continuous enlargement
and eventual rupture with a reported rupture rate of
2180% [6,9,24,36]. Mortality from rupture is sig-
nificant at 2143% [24,27]. Regardless of the pre-
sence of symptomatology, diagnosis of a PsA indicates
treatment.
Coil embolization is highly effective at controlling
bleeding. Embolization is associated with a 25% lower
mortality and less morbidity than surgical interven-
tion [7]. When embolizing the right and left hepatic
arteries, intrahepatic translobar collaterals usually
establish flow immediately and no infarction occurs
[37]. The two patients that underwent embolization
alone suffered no complications. However, three of
the four surgically managed patients had significant
sequelae. This cannot be solely attributed to the
surgical intervention because those patients under-
going surgery had complicated presentations and
co-morbidities, which likely impacted upon the post-
surgical course.
Although collateral circulation may prevent hepatic
infarction, this is not always the case and in some
circumstances, infarction may occur. There have been
reports of hepatic infarction with necrosis after
embolization due to sacrifice of the involved vessel
and risks end-organ thrombosis [3841]. Patients
with underlying liver disease, inadequate collateral
flow, or compromised hemodynamic status suffer
significant parenchymal infarction and develop liver
failure, which is associated with a mortality of 54%
[7]. The vessel may also recanalize and require repeat
embolization or surgical intervention. Patient 3
had undergone embolization prior to presenting to
our institution where the vessel was found to be
Figure 6. Celiac angiogram demonstrates a 5-cm pseudoaneurysm
of the right hepatic artery (arrow) adjacent to multiple surgical clips
from a prior laparoscopic cholecystectomy.
Figure 7. Post-embolization image demonstrates complete occlu-
sion of pseudoaneurysm.
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recanalized. Other complications include dislodge-
ment or migration of the obstructing material
[6,41], coil erosion into the common bile duct [42],
hepatic abscess formation and gallbladder fibrosis
[4,24].
Although less common, treatment with stent-graft
placement has been reported as an alternative to
selective arterial embolization when there is concern
about hepatic infarction or vascular recanalization.
These stents are a non-invasive method of excluding
the PsA and retaining hepatic arterial flow. There have
been recent case studies documenting the success of
stent-graft placement in the treatment of both asymp-
tomatic and ruptured PsA following liver transplanta-
tion and other biliary tract surgery [43,44]. Stent
placement requires an adequate length of normal
caliber artery on both sides of aneurysm to allow for
optimal placement. The need for anticoagulation
following stent-graft placement may be a contra-
indication for some patients.
Surgical management includes ligation or excision
of the PsA. Like embolization, serious complications
can ensue including hepatic necrosis resulting in
death, necessitating a liver transplantation, or requir-
ing hepatectomy. Surgery should be considered for
patients with PsA who fail embolization or have
coexisting complications requiring surgical interven-
tion.
Whether managed by hepatic arterial embolization
or surgical ligation and/or resection, these patients
require close monitoring during the post-operative
period for signs of complications secondary to occlu-
sion of hepatic arterial flow. Post-operative findings
that should prompt a search for complications of
arterial occlusion include persistently elevated or
rising hepatic transaminases, fever, elevated white
blood cell count and other signs of intraabdominal
sepsis. The possibility of complications may persist
well past the immediate post-interventional period, as
demonstrated by Patients 3 and 4, who presented with
complications 15 months and three years after their
respective right hepatic artery ligations.
Conclusions
Our six patients demonstrate the diversity and un-
predictability with which a PsA of the extrahepatic
arterial vasculature may present. Diagnosis is made
with a high index of clinical suspicion in conjunction
with radiological imaging. The recommended treat-
ment, if not precluded by underlying patient condi-
tion, is selective arterial embolization. This procedure
is associated with an excellent prognosis and it enables
precise PsA localization and hemorrhage control. The
alternative treatment is surgical arterial ligation with
or without PsA excision. Following embolization or
surgical management, patients must be monitored for
complications of impaired arterial flow.
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